Core Viewpoint - Momentus Inc. has received approximately $1.9 million in payments in January 2026 for contracts with NASA and the U.S. Air Force Research Laboratory's SpaceWERX organization, indicating ongoing collaboration and financial support from government entities [1]. Group 1 - The company is a U.S. commercial space firm that provides satellite buses, technologies, transportation, and various in-space services [1]. - The payments received are linked to the qualification and integration processes related to the contracts with NASA and AFRL's SpaceWERX [1].

Momentus Inc. 2026 Special Meeting Summary Company Overview - **Company**: Momentus Inc. (NasdaqCM: MNTS) - **Event**: 2026 Special Meeting of Stockholders - **Date**: February 06, 2026 Key Proposals Discussed 1. **Issuance of Class A Common Stock for Convertible Notes and Warrants** - Proposal to approve the issuance of Class A Common Stock in connection with the exercise of certain existing convertible notes and warrants exceeding 19.99% of outstanding shares, in accordance with Nasdaq Listing Rule 5635(d) [10] - Board recommends a vote for this proposal [10] 2. **Equity Line of Credit and Pre-Funded Warrants** - Proposal to approve the issuance of Class A Common Stock to an investor related to the company's Equity Line of Credit and the exercise of certain Pre-Funded Warrants, also exceeding 19.99% of outstanding shares [11] - Board recommends a vote for this proposal [11] 3. **October 2025 Inducement Warrants** - Proposal to approve the issuance of Class A Common Stock to holders of certain existing October 2025 inducement warrants, exceeding 19.99% of outstanding shares [12] - Board recommends a vote for this proposal [12] 4. **Increase in Authorized Shares** - Proposal to amend the company's certificate of incorporation to increase the number of authorized shares of Class A common stock from 250 million to 260 million [12] - Board recommends a vote for this proposal [12] 5. **December 2025 Inducement Warrants** - Proposal to approve the issuance of Class A Common Stock to holders of certain existing December 2025 inducement warrants, exceeding 19.99% of outstanding shares [13] - Board recommends a vote for this proposal [13] 6. **Postponement or Adjournment of Meeting** - Proposal to allow for the postponement or adjournment of the meeting if necessary to solicit further votes on the proposals [14] - Board recommends a vote for this proposal [14] 7. **January 2026 Warrants** - Proposal to approve the issuance of Class A Common Stock to holders of certain existing January 2026 warrants, exceeding 19.99% of outstanding shares [15] - Board recommends a vote for this proposal [15] Voting Results - Preliminary results indicated that the following proposals were approved: - Convertible note and warrants proposal - Equity line of credit proposal - October 2025 inducement warrant proposal - December 2025 inducement warrant proposal - Adjournment proposal - January 2026 warrant proposal - The share increase proposal was not approved [17] Additional Information - A quorum was declared present with more than one-third of Class A Common Stock represented [9] - The meeting was conducted virtually, allowing stockholders to vote online [4] - Final vote results will be reported to the SEC in a Form 8-K within four business days [17]

Core Viewpoint - Velo3D Inc. stock experienced a significant increase following Mears Machine Corporation's announcement of a major defense contract win, highlighting the strategic importance of this partnership in the defense sector [1] Group 1: Contract Details - Mears Machine Corporation secured a long-term supply agreement with a major U.S. defense original equipment manufacturer, which will involve manufacturing critical hardware for existing products and a new airframe platform [1] - The contract is projected to generate approximately $100 million in revenue over the first three years, with additional production and sustainment opportunities anticipated beyond this period [2] Group 2: Manufacturing Capabilities - Mears Machine operates four advanced Velo3D Sapphire XC large platform Laser Powder Bed Printers, enhancing its manufacturing capabilities [2] - To support the execution of the new contract and planned growth, Mears Machine is expanding its hiring across manufacturing and operations functions [2] Group 3: Recent Corporate Developments - Velo3D has secured significant defense contracts recently, including a $32.6 million contract with the Department of War under Project FORGE announced on December 22 [3] - The company collaborated with Momentus Inc. on a 3D-printed fuel tank for space testing, announced on January 5 [3] - On January 13, Velo3D entered a Cooperative Research and Development Agreement with the U.S. Army's DEVCOM Ground Vehicle Systems Center [3] Group 4: Upcoming Earnings - Investors are anticipating the next earnings report for Velo3D, scheduled for February 26 [4] Group 5: Stock Performance - Velo3D shares rose by 21.28% to $13.21 at the time of publication, reflecting positive market sentiment [5] - The earnings per share (EPS) estimate is a loss of 50 cents, with a revenue estimate of $8.50 million [5]

Core Viewpoint - Velo3D, Inc. has experienced a significant stock increase, reflecting positive market sentiment, particularly within the technology sector [1][3]. Recent Corporate Developments - Velo3D secured a $32.6 million contract with the Department of War under Project FORGE on December 22 [2]. - The company entered a Cooperative Research and Development Agreement with the U.S. Army's DEVCOM Ground Vehicle Systems Center on January 13 [2]. - Velo3D collaborated with Momentus Inc. on a 3D-printed fuel tank for space testing, announced on January 5 [2]. Technical Analysis - The stock is currently trading at $14.55, benefiting from broader upward momentum in the technology sector [3]. - Over the past year, Velo3D's stock has increased by 316.67%, indicating strong long-term momentum [4]. - The stock is trading 16% below its 20-day simple moving average (SMA), but 25.1% above its 50-day SMA and 81.2% above its 100-day SMA, suggesting a solid long-term uptrend [4]. Momentum Indicators - The Relative Strength Index (RSI) is at 46.57, indicating neutral territory, while the MACD is below its signal line, suggesting bearish pressure [5]. - These indicators reflect mixed momentum, with traders likely monitoring for potential bullish signals [5]. Earnings & Analyst Outlook - The next earnings report is anticipated on February 26, 2026 [6]. - The stock carries a Buy Rating with an average price target of $18, with recent analyst actions including a target raise by Lake Street to $18.00 [7]. - EPS is estimated to be a loss of 50 cents, with a revenue estimate of $8.50 million [7].

Group 1: Company Highlights - Above Food Ingredients Inc. Warrants (OTC:ABVEW) leads the market with an 81.74% increase, reaching $0.69, focusing on disruptive agriculture and international operations in sustainable food [1][7] - SMX (NASDAQ:SMX) follows with a 74.64% rise to $33.67, known for its brand protection and authentication technology, benefiting from innovative anti-counterfeit solutions and a strong financial outlook for 2026 [2][7] - Bristol-Myers Squibb Company Ce (CELG-RI) saw a 71.53% increase to $0.11, driven by advancements in small molecules and biologics, emphasizing drug manufacturing and healthcare treatments [3] - EUDA Health Holdings Limited (EUDAW) experienced a 67.29% rise to $0.12, focusing on virtual consults for non-emergency medical issues, gaining traction in the digital health sector [4] - Momentus Inc. (NASDAQ:MNTS) saw a 61.75% increase to $15.9, specializing in space transportation and in-orbit servicing, supported by industry developments and a recent $5 million private placement [5][7] Group 2: Industry Trends - The market is witnessing dynamic movements with sectors like sustainable food and space exploration capturing investor interest, highlighting the importance of unique industry positions and strategic developments [6]

Core Viewpoint - Premarket trading is showing significant activity with notable price movements indicating potential investment opportunities before the market opens [1] Premarket Gainers - Ventyx Biosciences, Inc. (VTYX) increased by 57% to $15.79 [3] - Cardio Diagnostics Holdings, Inc. (CDIO) rose by 36% to $4.02 [3] - Monte Rosa Therapeutics, Inc. (GLUE) saw a 28% increase to $20.54 [3] - Momentus Inc. (MNTS) gained 27% reaching $12.50 [3] - BioAge Labs, Inc. (BIOA) went up by 13% to $17.50 [3] - Neumora Therapeutics, Inc. (NMRA) increased by 11% to $2.03 [3] - Mobileye Global Inc. (MBLY) rose by 10% to $13.45 [3] - Society Pass Incorporated (SOPA) increased by 10% to $3.47 [3] - SU Group Holdings Limited (SUGP) saw an 8% rise to $6.32 [3] - Critical Metals Corp. (CRML) gained 7% reaching $12.73 [3] Premarket Losers - Evolution Metals & Technologies Corp. (EMAT) decreased by 28% to $15.20 [4] - Ascent Solar Technologies, Inc. (ASTI) fell by 12% to $4.65 [4] - Apogee Enterprises, Inc. (APOG) saw a 10% decline to $33.30 [4] - Next Technology Holding Inc. (NXTT) dropped by 8% to $8.49 [4] - AST SpaceMobile, Inc. (ASTS) decreased by 7% to $90.45 [4] - Nomadar Corp. (NOMA) fell by 7% to $3.66 [4] - EZGO Technologies Ltd. (EZGO) decreased by 7% to $1.99 [4] - Cohen & Company Inc. (COHN) saw a 6% decline to $28.30 [4] - PMGC Holdings Inc. (ELAB) dropped by 4% to $5.34 [4] - Anghami Inc. (ANGH) decreased by 3% to $4.49 [4]

Core Viewpoint - Momentus Inc. has entered into a securities purchase agreement with an existing institutional investor for the sale of 925,926 shares of common stock and warrants to purchase an additional 925,926 shares [1] Group 1: Company Overview - Momentus Inc. is a leading U.S. commercial space firm that specializes in satellite solutions, in-space transportation, and orbital infrastructure [1] Group 2: Financial Transaction - The agreement involves the purchase and sale of 925,926 shares of common stock or common stock equivalents [1] - The transaction also includes warrants that allow the purchase of up to 925,926 additional shares of common stock [1]

Market Performance - U.S. stocks experienced gains, with the Dow Jones index increasing by 1.66% to 49,183.51, the NASDAQ rising by 0.80% to 23,420.85, and the S&P 500 up by 0.81% to 6,913.76 [1] - European shares also saw positive movement, with the eurozone's STOXX 600 gaining 0.94%, Spain's IBEX 35 Index rising by 0.70%, London's FTSE 100 up by 0.54%, Germany's DAX increasing by 1.34%, and France's CAC 40 climbing by 0.20% [5] - Asian markets closed mostly higher, highlighted by Japan's Nikkei 225 gaining 2.97% and China's Shanghai Composite surging 1.38%, while India's BSE Sensex fell by 0.38% [6] Commodity Prices - In commodity trading, oil prices increased by 1.7% to $58.30, gold rose by 2.9% to $4,454.40, silver surged by 7.3% to $76.230, and copper climbed by 5.1% to $5.9815 [4] Company Developments - Momentus Inc (NASDAQ:MNTS) shares surged by 57% to $8.98 following the announcement of an additive-manufactured fuel tank for flight testing [8] - GH Research PLC (NASDAQ:GHRS) shares increased by 17% to $15.43 after the FDA lifted the clinical hold on its Investigational New Drug Application for GH001 [8] - VerifyMe Inc (NASDAQ:VRME) shares rose by 66% to $1.12 due to a strategic merger letter of intent with Open World [8] - Zenas Biopharma Inc (NASDAQ:ZBIO) shares dropped by 57% to $14.94 after announcing results from the Phase 3 INDIGO trial [8] - Palisade Bio Inc (NASDAQ:PALI) shares fell by 16% to $2.10, and Palvella Therapeutics Inc (NASDAQ:PVLA) decreased by 14% to $86.16 [8] Economic Indicators - The ISM manufacturing PMI declined for the third consecutive month to 47.9 in December, marking the lowest reading since October 2024, down from 48.2 in November and below market estimates of 48.3 [2][7]

Market Overview - U.S. stocks traded higher, with the Dow Jones index gaining over 250 points, up 0.54% to 48,641.58, NASDAQ up 0.65% to 23,386.57, and S&P 500 up 0.63% to 6,901.52 [1] - Energy shares increased by 2.9% on Monday [1] Sector Performance - Consumer staples stocks dipped by 0.4% [2] Commodity Prices - Oil traded up 1.4% to $58.12, gold up 2.4% to $4,433.50, silver up 7.5% to $76.320, and copper rose 4.1% to $5.9260 [5] European Market Performance - Eurozone's STOXX 600 gained 0.5%, Spain's IBEX 35 Index rose 0.3%, London's FTSE 100 up 0.4%, Germany's DAX gained 0.2%, and France's CAC 40 climbed 0.1% [6] Asian Market Performance - Asian markets closed mostly higher, with Japan's Nikkei 225 gaining 2.97%, Hong Kong's Hang Seng Index up 0.03%, China's Shanghai Composite surging 1.38%, while India's BSE Sensex fell 0.38% [7] Company News - The FDA lifted the clinical hold on GH Research Plc's Investigational New Drug Application for GH001 [3] - Momentus Inc shares surged 94% to $11.14 after announcing the development of an additive-manufactured fuel tank [9] - TMD Energy Ltd shares increased by 76% to $0.78 [9] - VerifyMe Inc shares rose 40% to $0.94 following a strategic merger announcement [9] - Zenas Biopharma Inc shares dropped 55% to $15.54 after Phase 3 trial results [9] - Signing Day Sports Inc shares fell 37% to $0.60, and Lavoro Ltd shares decreased by 26% to $0.82 [9]

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on December 19, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MOMENTUS INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 3714 84-1905538 (I.R.S. Employer Identification Number) 3901 N ...